ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
4,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Urticaria contact,Urticarias,Angioedema and urticaria,Skin,N
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
11,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
13,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
13,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
16,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
19,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
21,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
22,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
23,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
23,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
23,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
23,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
24,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
24,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
25,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
25,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
26,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
26,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
26,3,Product contamination chemical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
26,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
27,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,1,Biopsy stomach,Gastrointestinal histopathology procedures,Gastrointestinal investigations,Inv,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
31,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,2,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
35,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
36,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
37,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
38,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
38,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
39,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
40,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
40,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
40,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
42,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
43,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
44,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
45,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
45,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
45,3,Headache,Headaches NEC,Headaches,Nerv,N
45,4,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
45,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
45,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
45,7,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
45,8,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
45,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
45,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
46,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
46,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
47,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
47,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
47,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
48,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
48,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
49,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
49,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
49,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,5,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
49,6,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
49,7,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
50,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
50,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
50,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
52,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
53,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
56,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
57,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
57,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
57,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
